Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Teams with Immune Tolerance Institute to Create Immunology Center

NEW YORK (GenomeWeb News) – Beckman Coulter is collaborating with the Immune Tolerance Institute to establish a center that will study the roles that the human immune system plays in diseases, ITI said Monday.
 
The Institute, a non-profit corporation founded in part by the University of California, San Francisco, said the center initially will be sited at Beckman Coulter’s Cellular Analysis Business Group in Miami and it will integrate genomic, proteomic, bioinformatics, and cellular technologies to study immune functions in patients with immune-related and other diseases.
 
The center, called the Center for Critical Path Immunology, will work with academic and corporate partners to develop novel biomarkers that would be useful in developing new drugs and companion diagnostic tests, ITI said.
 
ITI is focused on developing cellular and molecular immunological assays to be used in immunotherapeutic development, and on analyzing the data from these assays in parallel with clinical safety and efficacy data using bioinformatics approaches.
 
The CCPI will be the “first step in bringing to fruition our mission to transform the drug discovery process to one that identifies promising therapies in their early phases of development, and that produces drug candidates that are safer, more highly targeted and effective in treating immune system-related diseases," ITI President and CEO Louis Matis said in a statement.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.